Filing Details
- Accession Number:
- 0000899243-19-000973
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2019-01-10 16:45:45
- Reporting Period:
- 2018-11-15
- Accepted Time:
- 2019-01-10 16:45:45
- Original Submission Date:
- 2018-11-19
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1707502 | Solid Biosciences Inc. | SLDB | Biological Products, (No Disgnostic Substances) (2836) | 900943402 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1727649 | Zev Solomon Joel Schneider | C/O Solid Biosciences Inc. 141 Portland Street, 5Th Floor Cambridge MA 02139 | See Remarks | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2018-11-15 | 13,448 | $30.68 | 133,198 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-11-15 | 8,542 | $31.10 | 124,656 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 24, 2018.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.99, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.00 to $31.70, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form.
- Amendment corrects arithmetical error as to number of securities in Column 5 of Table I.
Billionaire Hedge Funds
